Test the Efficacy of Antiplatelet Regimes in Acute Stroke Clinical Trial
Official title:
Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
The aim of this study is to evaluate the low-response prevalence of early antiplatelet therapy and to test the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).
Antiplatelet agents are important therapeutic options in treating patients with acute ischemic strokes to prevent recurrent ischemic events or death. The aim of this study was to evaluate the low-response prevalence of early antiplatelet therapy and the influence of different aspirin dosages in patients with acute ischemic strokes (AIS). ;
Observational Model: Case-Only, Time Perspective: Retrospective